X

Vous n'êtes pas connecté

Maroc Maroc - DAILYNEWSEGYPT.COM - Global - 23/01/2025 14:44

Russian Scientists Develop Targeted Cancer Therapy

Laboratorium: Russian scientists are developing a new method for identifying and treating cancers. The therapy aims to deliver medication directly to a patient’s tumour via the bloodstream, minimising damage to healthy tissues. The technology is designed to target tumours specifically, reducing the systemic side effects often associated with traditional cancer treatments like chemotherapy, which can […]

Articles similaires

Pre-surgical medication use grows for pancreatic, gynecologic, and abdominal lining cancers

news.medical.net - 22/Jan 19:25

The second annual report from the National Cancer Database (NCDB) of the American College of Surgeons (ACS) documents a substantial rise in medication...

Pre-surgical medication use grows for pancreatic, gynecologic, and abdominal lining cancers

news.medical.net - 22/Jan 19:25

The second annual report from the National Cancer Database (NCDB) of the American College of Surgeons (ACS) documents a substantial rise in medication...

Blood test could bolster brain cancer survival rates

thewest.com.au - 30/Jan 19:01

Australian scientists have developed a diagnostic device that uses a patient's blood to analyse how deadly brain tumours are responding to medical...

Blood test could bolster brain cancer survival rates

thewest.com.au - 30/Jan 19:01

Australian scientists have developed a diagnostic device that uses a patient's blood to analyse how deadly brain tumours are responding to medical...

Sorry! Image not available at this time

Big breakthrough! Spanish research team cure pancreatic cancer in mice. Here's what we know about therapy

wn.com - 29/Jan 18:13

Pancreatic ductal adenocarcinoma is one of the deadliest cancers due to its late detection, dense tumour structure, and resistance to conventional...

PBS listing announced for treatment of unresectable or metastatic, well-differentiated extra-pancreatic or pancreatic neuroendocrine tumours

oncologynews.com.au - 24/Jan 02:01

Ipsen Australia welcomes the Pharmaceutical Benefits Scheme (PBS) listing of Cabometyx® (cabozantinib) for the treatment of patients with...

PBS listing announced for treatment of unresectable or metastatic, well-differentiated extra-pancreatic or pancreatic neuroendocrine tumours

oncologynews.com.au - 24/Jan 02:01

Ipsen Australia welcomes the Pharmaceutical Benefits Scheme (PBS) listing of Cabometyx® (cabozantinib) for the treatment of patients with...

Scientists find a hidden weakness in deadly blood cancer

knowridge.com - 22/Jan 00:53

Acute myeloid leukemia, often called AML, is one of the most aggressive and difficult blood cancers to treat. Every year thousands of people are...

Scientists find a hidden weakness in deadly blood cancer

knowridge.com - 22/Jan 00:53

Acute myeloid leukemia, often called AML, is one of the most aggressive and difficult blood cancers to treat. Every year thousands of people are...

Sorry! Image not available at this time

Opdivo® (nivolumab) with chemotherapy before surgery then alone after surgery recommended for use on the NHS when treating adult patients with resectable NSCLC

wn.com - 21/Jan 10:39

Nivolumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) has been recommended by the National Institute for Health...

Les derniers communiqués